Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.

Marc Radtke; R Fölster-Holst; Florian Beikert; Katharina Herberger; Matthias Augustin

Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.

Standard

Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics. / Radtke, Marc; Fölster-Holst, R; Beikert, Florian; Herberger, Katharina ; Augustin, Matthias.

in: GIORN ITAL DERMAT V, Jahrgang 146, Nr. 1, 1, 2011, S. 31-45.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Radtke, M, Fölster-Holst, R, Beikert, F, Herberger, K & Augustin, M 2011, 'Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.', GIORN ITAL DERMAT V, Jg. 146, Nr. 1, 1, S. 31-45. <http://www.ncbi.nlm.nih.gov/pubmed/21317855?dopt=Citation>

APA

Radtke, M., Fölster-Holst, R., Beikert, F., Herberger, K., & Augustin, M. (2011). Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics. GIORN ITAL DERMAT V, 146(1), 31-45. [1]. http://www.ncbi.nlm.nih.gov/pubmed/21317855?dopt=Citation

Vancouver

Radtke M, Fölster-Holst R, Beikert F, Herberger K , Augustin M. Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics. GIORN ITAL DERMAT V. 2011;146(1):31-45. 1.

Bibtex

@article{cbe22ba97090426285446c6fc16bbd58,

title = "Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.",

abstract = "Childhood psoriasis is a well-known entity, which is different from adult onset psoriasis in many ways. Recent data from Germany, where a total of 33981 patients with psoriasis were identified from a database of about 1.3 million non-selected persons of a German statutory health insurance, revealed a total rate of 0.71% in children younger than 18 years. The prevalence rates increased in a linear way from 0.2% at the age of one year to 1.2% at the age of 18 years. Although the different types of psoriasis are present in both children and adults, the individual course of the disease and its distribution shows differences. The overall rate of comorbidity in psoriatic persons younger than 20 years seems to be twice as high as in persons without psoriasis. Treating children with psoriasis still remains challenging and represents one of the most rewarding endeavours in contemporary dermatology, since psoriasis can present with both joint and skin symptoms. An interdisciplinary approach with pediatricians, dermatologist and rheumatologists might be crucial. The multifactorial etiology of the disease has led to the development of a wide variety of different treatments, providing physicians with a multitude of options that must be tailored to the age of the patient and the severity of their symptoms. The provision of adequate care for juvenile psoriasis patients depends to a large extent on a precise knowledge of the range of severity and burden imposed by the disease.",

keywords = "Comorbidity, Diagnosis, Differential, Humans, Male, Female, Adolescent, Quality of Life, Child, Clinical Trials as Topic, Child, Preschool, Infant, Prevalence, Age of Onset, Germany/epidemiology, Antibodies, Monoclonal/therapeutic use, Immunosuppressive Agents/therapeutic use, Anti-Inflammatory Agents/therapeutic use, Crohn Disease/epidemiology, Dermatologic Agents/therapeutic use, *Dermatology, Metabolic Syndrome X/epidemiology, Nails/pathology, PUVA Therapy, *Pediatrics, *Psoriasis/diagnosis/drug therapy/epidemiology/pathology, Scalp/pathology, Comorbidity, Diagnosis, Differential, Humans, Male, Female, Adolescent, Quality of Life, Child, Clinical Trials as Topic, Child, Preschool, Infant, Prevalence, Age of Onset, Germany/epidemiology, Antibodies, Monoclonal/therapeutic use, Immunosuppressive Agents/therapeutic use, Anti-Inflammatory Agents/therapeutic use, Crohn Disease/epidemiology, Dermatologic Agents/therapeutic use, *Dermatology, Metabolic Syndrome X/epidemiology, Nails/pathology, PUVA Therapy, *Pediatrics, *Psoriasis/diagnosis/drug therapy/epidemiology/pathology, Scalp/pathology",

author = "Marc Radtke and R F{\"o}lster-Holst and Florian Beikert and Katharina Herberger and Matthias Augustin",

year = "2011",

language = "English",

volume = "146",

pages = "31--45",

journal = "GIORN ITAL DERMAT V",

issn = "0392-0488",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "1",

}

RIS

TY - JOUR

T1 - Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics.

AU - Radtke, Marc

AU - Fölster-Holst, R

AU - Beikert, Florian

AU - Herberger, Katharina

AU - Augustin, Matthias

PY - 2011

Y1 - 2011

N2 - Childhood psoriasis is a well-known entity, which is different from adult onset psoriasis in many ways. Recent data from Germany, where a total of 33981 patients with psoriasis were identified from a database of about 1.3 million non-selected persons of a German statutory health insurance, revealed a total rate of 0.71% in children younger than 18 years. The prevalence rates increased in a linear way from 0.2% at the age of one year to 1.2% at the age of 18 years. Although the different types of psoriasis are present in both children and adults, the individual course of the disease and its distribution shows differences. The overall rate of comorbidity in psoriatic persons younger than 20 years seems to be twice as high as in persons without psoriasis. Treating children with psoriasis still remains challenging and represents one of the most rewarding endeavours in contemporary dermatology, since psoriasis can present with both joint and skin symptoms. An interdisciplinary approach with pediatricians, dermatologist and rheumatologists might be crucial. The multifactorial etiology of the disease has led to the development of a wide variety of different treatments, providing physicians with a multitude of options that must be tailored to the age of the patient and the severity of their symptoms. The provision of adequate care for juvenile psoriasis patients depends to a large extent on a precise knowledge of the range of severity and burden imposed by the disease.

AB - Childhood psoriasis is a well-known entity, which is different from adult onset psoriasis in many ways. Recent data from Germany, where a total of 33981 patients with psoriasis were identified from a database of about 1.3 million non-selected persons of a German statutory health insurance, revealed a total rate of 0.71% in children younger than 18 years. The prevalence rates increased in a linear way from 0.2% at the age of one year to 1.2% at the age of 18 years. Although the different types of psoriasis are present in both children and adults, the individual course of the disease and its distribution shows differences. The overall rate of comorbidity in psoriatic persons younger than 20 years seems to be twice as high as in persons without psoriasis. Treating children with psoriasis still remains challenging and represents one of the most rewarding endeavours in contemporary dermatology, since psoriasis can present with both joint and skin symptoms. An interdisciplinary approach with pediatricians, dermatologist and rheumatologists might be crucial. The multifactorial etiology of the disease has led to the development of a wide variety of different treatments, providing physicians with a multitude of options that must be tailored to the age of the patient and the severity of their symptoms. The provision of adequate care for juvenile psoriasis patients depends to a large extent on a precise knowledge of the range of severity and burden imposed by the disease.

KW - Comorbidity

KW - Diagnosis, Differential

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Quality of Life

KW - Child

KW - Clinical Trials as Topic

KW - Child, Preschool

KW - Infant

KW - Prevalence

KW - Age of Onset

KW - Germany/epidemiology

KW - Antibodies, Monoclonal/therapeutic use

KW - Immunosuppressive Agents/therapeutic use

KW - Anti-Inflammatory Agents/therapeutic use

KW - Crohn Disease/epidemiology

KW - Dermatologic Agents/therapeutic use

KW - Dermatology

KW - Metabolic Syndrome X/epidemiology

KW - Nails/pathology

KW - PUVA Therapy

KW - Pediatrics

KW - Psoriasis/diagnosis/drug therapy/epidemiology/pathology

KW - Scalp/pathology